The ‘Road to Next’ series by Deloitte explores the tremendous growth in the health tech industry, which has seen the deal value and count exceed all previous heights. The health tech takes advantage of an array of macro and key markets conditions, spanning demographics, increasing viability of key underlying technologies, and more.
The health tech firms have expanded to several niches. They are targeting various markets such as telehealth, mobile clinic back-end platforms, and data analytics platforms that support predictive personalization for patients.
A record level of funding has been witnessed in recent years. Each quarter f 2021 has recorded over $70 billion in expansion-stage deal value with $221.3 billion invested across more than 4,500 completed expansion-stage financings. Global deal-making has significantly to those tallies, with corporate players actively participating in around 25% of all 2021 expansion-stage deals to date, which makes a hefty 59.2% of deal value.
